Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
T3 Defense Inc. announced it has regained compliance with Nasdaq's minimum stockholders' equity requirement of $10 million. The company resolved a previous deficiency caused by the non-cash liability classification of warrants, which had temporarily driven stockholders' equity into a deficit. Following the exercise of 96% of those warrants, the company reported pro forma stockholders' equity of approximately $99.9 million as of September 30, 2026.
Lunai Bioworks received a Nasdaq delisting determination for failing to maintain the minimum stockholders' equity requirement of $2.5 million, reporting a deficit of over $9 million. The company has decided not to appeal the decision and will voluntarily delist its common stock from Nasdaq and deregister with the SEC to save costs.
Atlantic American Corporation received a staff delisting determination from Nasdaq on October 16, 2026, due to its failure to timely file its 2025 Annual Report and two subsequent 2026 Quarterly Reports. The company has since filed its 2025 Form 10-K and intends to appeal the delisting notice by requesting a hearing before a Nasdaq Hearings Panel to stay the suspension of its common stock. The company is working to file the remaining delinquent reports to regain compliance with Nasdaq Listing Rule 5250(c)(1).
ARC Group Acquisition I Nasdaq/NYSE Compliance Notice
ARC Group Acquisition I Corp. received an extension from Nasdaq until February 23, 2027, to regain compliance with the $1 million minimum aggregate market value requirement for its warrants. The company expects to regain compliance by completing its previously announced business combination before the deadline. If compliance is not met by the extension date, the company's securities face potential delisting.
Globa Terra Acquisition Nasdaq/NYSE Compliance Notice
Globa Terra Acquisition Corp received a delisting notice from Nasdaq for failing to complete a business combination within the required 15-month timeframe specified in its IPO registration statement. The company intends to request a hearing before a Nasdaq Hearing Panel to appeal the determination, which will stay the delisting process pending a decision.
SenesTech received a deficiency notice from Nasdaq on October 20, 2026, because its common stock bid price closed below $1.00 for 30 consecutive business days. The company has 180 calendar days, until April 19, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for 10 consecutive business days. Management highlighted record preliminary Q3 revenue of $1.1 million alongside the notice to demonstrate business progress.
TruGolf Holdings, Inc. announced that it believes it has regained compliance with Nasdaq's $2.5 million minimum stockholders' equity requirement following the completion of its acquisition of Polymath Research Inc. and a $2.95 million Series B preferred stock financing. Nasdaq will continue to monitor the company's compliance through its next periodic report to ensure the requirement remains satisfied.
Direct Digital Holdings Nasdaq/NYSE Compliance Notice
Direct Digital Holdings, Inc. has notified Nasdaq of its intention to voluntarily delist its Class A common stock and deregister with the SEC. The decision follows a prior delisting determination from Nasdaq on October 1, 2026, due to the company's failure to comply with minimum listing requirements, which resulted in a trading suspension on October 5, 2026.
Alaunos Therapeutics received a delisting notice from Nasdaq on October 5, 2026, due to continued non-compliance with the $2.5 million minimum stockholders' equity requirement. The company has requested a hearing before the Nasdaq Hearings Panel, currently scheduled for November 10, 2026, which has stayed any delisting action pending the outcome.
Valor Energy Inc received a deficiency notice from Nasdaq for failing to meet the minimum stockholders' equity requirement of $2.5 million. The company reported a stockholders' deficit of $35.3 million as of June 30, 2026, primarily due to the classification of warrants as derivative liabilities. The company has 45 days to submit a plan to regain compliance.
Vivos Therapeutics received a letter from Nasdaq confirming that the company has regained compliance with the minimum stockholders' equity requirement of $2.5 million under Listing Rule 5550(b)(1). The compliance was achieved following a transaction involving the issuance of Series C Convertible Preferred Stock, which is expected to increase stockholders' equity by more than $10 million. The company must continue to evidence compliance in its next periodic report to avoid potential delisting.
Sports Entertainment Gaming Global Nasdaq/NYSE Compliance Notice
Sports Entertainment Gaming Global Corp received a Nasdaq Staff Determination letter on October 14, 2026, notifying the company of a delisting threat due to its failure to file its Q2 2026 Form 10-Q. The company has requested a hearing before the Nasdaq Hearings Panel to stay the suspension of its common stock and warrants and present a plan to regain compliance.
SHF Holdings received a formal 180-day extension from Nasdaq, until April 19, 2027, to regain compliance with the $1.00 minimum bid price requirement. The company met all other listing standards and has notified Nasdaq of its intent to cure the deficiency, potentially through a reverse stock split if necessary.
DataMeds AI, Inc. received formal notification from Nasdaq on October 19, 2026, confirming that the company has regained compliance with the $2.5 million minimum stockholders' equity requirement for continued listing. The company had previously been in deficiency since April 2026 and had also recently regained compliance with the minimum bid-price requirement in June 2026.
XWELL, Inc. received a deficiency notice from Nasdaq on October 7, 2026, because its common stock failed to maintain a minimum bid price of $1.00 for 30 consecutive business days. The company has 180 calendar days, or until April 5, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for ten consecutive business days. XWELL is monitoring the situation and considering options, including a potential reverse stock split, to address the deficiency.
Stardust Power Inc. received a Staff Delisting Determination from Nasdaq on October 15, 2026, after its common stock closed at $0.10 or less for ten consecutive trading days. Nasdaq intends to suspend trading and delist the company's securities on October 23, 2026, though the company may appeal the decision to the Nasdaq Hearings Panel.
PLAYSTUDIOS, Inc. has regained compliance with Nasdaq's $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market. The company achieved this by maintaining a closing bid price at or above $1.00 for ten consecutive business days following a 1-for-10 reverse stock split effected on September 30, 2026.
Apollo Commercial Real Estate Finance Nasdaq/NYSE Compliance Notice
Apollo Commercial Real Estate Finance, Inc. announced it will voluntarily delist its common stock from the NYSE on or about October 27, 2026, with the last day of trading expected to be November 6, 2026. This action is part of the company's Plan of Complete Liquidation and Dissolution, which involves transferring remaining assets to a liquidating trust and deregistering with the SEC. Following the transfer, stockholders will receive non-transferable beneficial interests in the trust on a one-for-one basis.
Bridgeline Digital received a deficiency notice from Nasdaq on October 14, 2026, because its common stock failed to maintain a minimum bid price of $1.00 per share for 30 consecutive business days. The company has 180 calendar days, until April 12, 2027, to regain compliance by maintaining a $1.00 bid price for at least 10 consecutive business days.
Canopy Growth Corporation received a deficiency notice from Nasdaq on October 14, 2026, because its common shares closed below the $1.00 minimum bid price for 30 consecutive business days. The company has until April 12, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for ten consecutive business days. Canopy Growth is currently seeking shareholder approval for a potential reverse stock split at its upcoming annual meeting to address the deficiency.
Lucid Diagnostics Inc. received a deficiency notice from Nasdaq on October 12, 2026, because its common stock closing bid price fell below the $1.00 minimum requirement for 30 consecutive business days. The company has 180 calendar days, until April 12, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for ten consecutive business days.
Health In Tech received two deficiency notices from Nasdaq regarding its failure to maintain a majority of independent directors on its board and for its stock price falling below the $1.00 minimum bid requirement for 30 consecutive days. The company has until April 12, 2027, to regain compliance with the bid price rule and until its next annual meeting to resolve the board independence issue. Management expects to regain compliance following the election of a new independent director at the annual meeting scheduled for November 10, 2026.
eHealth, Inc. received a deficiency notice from Nasdaq on October 14, 2026, because its common stock closed below the $1.00 minimum bid price for 30 consecutive business days. The company has 180 calendar days, until April 12, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for 10 consecutive business days. Management is considering options to regain compliance, including a potential reverse stock split or transferring to the Nasdaq Capital Market.
Callan JMB Inc. received a Staff Determination letter from Nasdaq on October 12, 2026, notifying the company of its failure to regain compliance with the $2.5 million minimum stockholders' equity requirement. The company has requested a hearing before a Nasdaq Hearings Panel to appeal the delisting determination, which stays the suspension of its common stock pending the Panel's decision.
Aether Holdings received a deficiency notice from Nasdaq for failing to hold an annual meeting of shareholders within 12 months of its fiscal year end. The company has until November 27, 2026, to submit a compliance plan and may be granted until March 29, 2027, to regain compliance.
SITE Centers Corp. has provided written notice to the NYSE of its intention to voluntarily delist its common shares. The company expects the delisting to become effective prior to the commencement of trading on December 4, 2026, following the sale of its interests in the Dividend Trust Portfolio joint venture.
Cyngn Inc. received a deficiency notice from Nasdaq on October 14, 2026, because its common stock closing bid price fell below the $1.00 minimum requirement for 30 consecutive business days. The company has 180 calendar days, or until April 12, 2027, to regain compliance by maintaining a bid price of at least $1.00 for at least 10 consecutive business days.
Innovative Eyewear received a deficiency notice from Nasdaq on October 9, 2026, because its common stock closed below the $1.00 minimum bid price for 30 consecutive business days. The company has 180 calendar days, until April 7, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for 10 consecutive business days.
Mustang Bio received a second 180-day grace period from Nasdaq, until April 12, 2027, to regain compliance with the $1.00 minimum bid price requirement. The company intends to monitor its stock price and may effect a reverse stock split if necessary to maintain its listing on the Nasdaq Capital Market.
Quantum-Si Incorporated has regained compliance with Nasdaq's minimum bid price requirement as its Class A common stock maintained a closing bid price of at least $1.00 per share for 10 consecutive business days. The company had previously received a deficiency notice on July 23, 2026, and Nasdaq has now officially closed the matter.